Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants G Terrero et al, JAMA Oncology, April 21, 2022

Main|Search|PHGKB